Day 2, Thursday, 27th August 2026
08.00 – 09.00
Messe Zürich, Room 1, Hall 7, Level 3
Workshop 1: Dermatopathology
Role of dermatopathology in targeted therapy ()
08.00- 08.15
Histopathological Aspects of PD-1 und PDL-1 inhibitors induced cutaneous adverse events"
Isabel Kolm-Djamei ()
08.15 – 08.30
Selected cutaneous tumors harboring mutations/fusions as potential neoplasms for targeted therapy
Dmitry Kazakov ( IDP Institute for Dermatohistopathology, Zurich)
08.30 – 08.45
Cutaneous toxicities associated with enfortumab vedotin & pembrolizumab
Hazem Juratli (Zurich, Switzerland)
08.45 – 09.00
Rituximab in Skin Diseases: A Dermatopathologic Perspective
Natalja Denisjuk (St. Gallen, Switzerland)
Chair: Natalja Denisjuk
08.15 – 09.00
Messe Zürich, ROOM 2, Quickspace, Hall 5
Workshop 2: Dermato-Allergology
New therapeutic targets in urticaria and mastocytosis
Karin Hartmann (Basel, USB)
New therapeutic targets in urticaria and mastocytosis
to be confirmed ()
Chair: Susanne Radonjic
08.15 – 09.00
Messe Zürich, ROOM 3, Quickspace, Hall 5
Workshop 3: Swiss Young Dermatologists
TBD
tbd ()
Chair: Julia Zinsli
08.15 – 09.00
Messe Zürich, ROOM 4, K6, Level 3
Workshop 4: Dermato-Oncology
Cutaneous complex tumors in a live Tumor Board discussion Bellinzona-Zurich: from evidence based to real world ()
Egle Ramelyte (Zurich, Switzerland)
Marie-Luise Hilbers (Bellinzona. Switzerland)
Chair: Cristina Mangas / Johanna Mangana
09.00 – 09.10
Coffee break / Exhibition
09.10 – 09.55
Messe Zürich, Room 1, Hall 7, Level 3
Workshop 5: Free Communications
Abstracts selected by the Scientific Committee (USZ, Zürich)
Abstract 1
Abstract 2
Abstract 3
Abstract 4
Abstract 5
Chairs: Curdin Conrad / Christoph Schlapbach
09.10 – 09.55
Messe Zürich, ROOM 2, Quickspace, Hall 5
Workshop 6: Trichology
Insights from the Swiss Trichology Group: Antifungal Resistance in Tinea capitis (And Onychomycosis). Causes, Consequences And Prevention Strategies
Christin Pelzer (St. Gallen, Switzerland,)
Myth vs reality on post finasteride syndrome
Ramon Grimalt (Terrassa, Spain)
Chairs: Matilde Iorizzo, Pierre de Viragh
09.10 – 09.55
Messe Zürich, ROOM 3, Quickspace, Hall 5
Workshop 7: Esthetic Medicine
Introduction
Oliver Kreyden (Muttenz, Switzerland)
Polylactid Acid : From Fillers to Biostimulation
Daniel Fuchs (Zurich, Switzerland)
Calcium Hydroxylapatite (CaHa) for Biostimulation
Monika Hess Schmid (Zurich, Switzerland)
Exosomes and Polypeptides for Biostimulation-
Patrizia Carrozza Merlani (Bellinzona, Switzerland)
Chairs: Oliver Kreyden / Monika Hess Schmid
09.10 – 09.55
Messe Zürich, ROOM 4, K6, Level 3
Workshop 8: Psychodermatology
TBD
To be defined ()
Chairs: Oliver Das / Siegfried Borelli
10.00-10.15
Poster Viewing
10.15-12.00
Messe Zürich, Room 1, Hall 7, Level 3
SSDV General Assembly 2026
12.00 – 12.30
Messe Zürich, Hall 7, Level 3
Posterwalk
12.00 – 12.30
Walk 2
Laurence Feldmeyer (Lucerne., Switzerland)
12.00 – 12.30
Walk 3
Egle Ramelyte (Zürich, Switzerland)
12.00 – 14.00
Lunch / Exhibition / Poster Gallery
12.30 – 13.00
Messe Zürich, Room 1, Hall 7, Level 3
Symposium 4:
To be defined ()
Chair: to be defined
Sanofi
12.30 – 13.00
Messe Zürich, ROOM 2, Quickspace, Hall 5
Satellite 4: The future in psoriasis: Innovative therapies and their potential for everyday clinical practice
Nikhil Yawalkar (Bern, Switzerland)
Peter Häusermann (Basel, Switzerland)
Curdin Conrad (Lausanne,Switzerland)
Chair: Nikhil Yawalkar
Janssen Cilag
12.30 – 13.00
Messe Zürich, ROOM 3, Quickspace, Hall 5
Satellite 7: Beyond the Skin: Obesity, an important metabolic comorbidity in psoriasis? – From Evidence to Practical Action
Setting the Stage: The Evolving PsO Landscape and Therapeutic Challenges in the Context of Obesity Navigating Barriers to Optimal Disease Control
Susanne Maurer (Winterthur, Switzerland)
Beyond Comorbidity: The Role of Obesity in Immune-Mediated Diseases
Susanne Maurer (Winterthur, Switzerland)
Bridging Evidence and Practice: What Trials and Real-World Evidence Reveal Leveraging Combination Therapiesand Multidisciplinary Care
Florian Anzengruber (Chur, Switzerland)
Innovations in Obesity Management for PsO Patients: Translating Evidence into Practice
Florian Anzengruber (Chur, Switzerland)
Chair: to be defined
Eli Lilly
13.10 – 13.40
Messe Zürich, Room 1, Hall 7, Level 3
Symposium 5:
to be defined ()
Chair: to be defined
Abbvie
13.10 – 13.40
Messe Zürich, ROOM 2, Quickspace, Hall 5
Satellite 5: Guidelines and Innovation in Urticaria: The Role of Remibrutinib
Management Today: International Guidelines and the CSU Therapeutic Landscape
Torsten Zuberbier (Berlin, Germany)
Urticaria Treatment: Focus on Remibrutinib in CSU and Emerging Data
Claudia Lang (Zurich, Switzerland)
Chair: Torsten Zuberbier
Novartis
13.10 – 13.40
Messe Zürich, ROOM 3, Quickspace, Hall 5
Satellite 8:
to be defined ()
Chair: to be defined
LEO Pharma
13.40- 13.45
Short break
13.45 – 14.15
Messe Zürich, Room 1, Hall 7, Level 3
Symposium 6:
to be defined ()
Chair: to be defined
INcyte
13.45 – 14.15
Messe Zürich, ROOM 2, Quickspace, Hall 5
Satellite 6:
to be defined ()
Chair: to be defined
UCB Pharma
13.45 – 14.15
Messe Zürich, ROOM 3, Quickspace, Hall 5
Satellite 9: From Data to Patients: Real-World Experience and New Insights with IL-31 Blockade
Karin Hartmann (Basel, Switzerland)
Ieva Saulite (St. Gallen, Switzerland)
Chair: Nikhil Yawalkar
Galderma
14.15- 14.30
Short break
14.30 – 15.00 / Honorary Lecturre
Messe Zürich, Room 1, Hall 7, Level 3
New therapeutic approaches to fibrotic skin diseases
Thomas Krieg (Cologne, Germany)
Chair: to be defined
15.00 – 15.30 / Key Note Lecture
Messe Zürich, Room 1, Hall 7, Level 3
Lecture to be defined
TBD ()
Chair: to be defined
15.30 – 15.50
Coffee break / Exhibition
15.50 – 16.20 / Key Note Lecture
Messe Zürich, Room 1, Hall 7, Level 3
Development of melanoma treatment
Reinhard Dummer (Zurich, Switzerland)
Chair: to be defined
16.20 – 16.50 / What's new
Messe Zürich, Room 1, Hall 7, Level 3
Honorary Lecture
Christian Surber (Basel, Switzerland)
Chairs: to be defined
16.30 – 16.40
Coffee break / Credits
17.00 – 17.45
Messe Zürich, Room 1, Hall 7, Level 3
Workshop 9: Laser
Neues aus der Laser Medizin in der Behandlung der Hidradenitis suppurativa
David Alvarez (Geneva, Switzerland)
Analgesie in der pediatrischen Lasermedizin – Literatur und praktische Anwendung
Mael Blanchard (Geneva, Switzerland)
Prevenir les cancer de la peau par Laser – un mythe, un rêve ou deja la réalité?
HJ Laubach (Geneva, Switzerland)
Tbd
Natalie Anasiewicz (USZ, Zürich)
Chair: HJ Laubach
17.00 – 17.45
Messe Zürich, ROOM 2, Quickspace, Hall 5
Workshop 10: Dermatosurgery
TBD ()
Chairs: Michael Mühlstädt
17.00 – 17.45
Messe Zürich, ROOM 3, Quickspace, Hall 5
Workshop 11: Teledematology
A 360° view of digital dermatology
Florian Anzebrguber (Chur, Switzerland)
Teledermatology 2026
Christian Greis (Zürich, Switzerland)
AI in Dermatology
Alexander Navarini (Basel, Switzerland)
Chair: Florian Anzengruber
17.00 – 17.45
Messe Zürich, ROOM 4, K6, Level 3
Workshop 12: Radiotherapy
Egle Ramelyte (USZ, Zürich)
Chairs: Egle Ramelyte
17.45 – 17.50
Short break
17.50 – 18.20
Messe Zürich, ROOM 2, Quickspace, Hall 5
Satellite 10:
Louis Widmer
19.00 – 23.00
Congress Dinner @ Aura ZH